Mortality surrogates in combined pulmonary fibrosis and emphysema.

Greater numbers of CPFE patients with ≥10% emphysema demonstrated 1-year DLco declines ≥15%, though again results did not reach statistical significance ( Table 3 ).

also in 111,027 other papers